{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-DLDR4TUT/90296ba5-3503-443b-8ac6-77b322a0c97b/HTML","dcterms:extent":"40 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-DLDR4TUT/ed77bf43-6b13-4936-bdce-1661b6bf2004/PDF","dcterms:extent":"224 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-DLDR4TUT/da407f9d-e2b4-44bb-a30e-0a23d95a6d8b/TEXT","dcterms:extent":"27 KB"}],"edm:TimeSpan":{"@rdf:about":"1992-2025","edm:begin":{"@xml:lang":"en","#text":"1992"},"edm:end":{"@xml:lang":"en","#text":"2025"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:doc-DLDR4TUT","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/URN:NBN:SI:spr-FNIFVE9S"},{"@xml:lang":"sl","#text":"Radiology and oncology (Ljubljana)"}],"dcterms:issued":"2008","dc:creator":["Ocvirk, Janja","Reberšek, Martina"],"dc:format":[{"@xml:lang":"sl","#text":"številka:4"},{"@xml:lang":"sl","#text":"letnik:42"},{"@xml:lang":"sl","#text":"str. 215-224"}],"dc:identifier":["ISSN:1318-2099","COBISSID:692603","URN:URN:NBN:SI:doc-DLDR4TUT"],"dc:language":"en","dc:publisher":{"@xml:lang":"sl","#text":"Association of Radiology and Oncology"},"dc:subject":[{"@xml:lang":"en","#text":"Acneiform eruptions"},{"@xml:lang":"en","#text":"Adverse effects"},{"@xml:lang":"en","#text":"Antibodies monoclonal"},{"@xml:lang":"en","#text":"Carcinoma, squamous cell"},{"@xml:lang":"sl","#text":"cetuximab"},{"@xml:lang":"en","#text":"Colorectal neoplasms"},{"@xml:lang":"sl","#text":"danka"},{"@xml:lang":"en","#text":"Drug therapy"},{"@xml:lang":"sl","#text":"kožne spremembe"},{"@xml:lang":"sl","#text":"neželeni učinki"},{"@xml:lang":"sl","#text":"rak (medicina)"},{"@xml:lang":"en","#text":"Therapeutic use"},{"@xml:lang":"en","#text":"Therapy"},{"@xml:lang":"en","#text":"Vitamin K1"},{"@xml:lang":"sl","#text":"zdravljenje"}],"dcterms:temporal":{"@rdf:resource":"1992-2025"},"dc:title":{"@xml:lang":"sl","#text":"Management of cutaneous side effects of cetuximab therapy with vitamin K1 creme|"},"dc:description":{"@xml:lang":"sl","#text":"Radiology and Oncology je revija, ki objavlja izvirne in pregledne znanstvene članke iz diagnostične in intervencijske radiologije, nuklearne medicine, ultrazvočne diagnostike, radioterapije, klinične in eksperimentalne onkologije, radiobiologije, radiofizike ter zaščite pred sevanjem. Revija Radiology and Oncology izhaja štirikrat letno, v angleškem jeziku. Sedež revije je na Onkološkem inštitutu v Ljubljani. "},"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:doc-DLDR4TUT","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:doc-DLDR4TUT"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:doc-DLDR4TUT/ed77bf43-6b13-4936-bdce-1661b6bf2004/PDF"},"edm:rights":{"@rdf:resource":"http://creativecommons.org/licenses/by/4.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Društvo radiologije in onkologije"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:doc-DLDR4TUT/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:doc-DLDR4TUT"}}}}